Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2009 Feb;26(2):382-94.
doi: 10.1007/s11095-008-9755-4. Epub 2008 Oct 29.

Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug

Olga B Garbuzenko  1 , Maha Saad, Seema Betigeri, Min Zhang, Alexandre A Vetcher, Viatcheslav A Soldatenkov, David C Reimer, Vitaly P Pozharov, Tamara Minko
Affiliations
Comparative Study

Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug

Olga B Garbuzenko et al. Pharm Res. 2009 Feb.

Abstract

Purpose: To compare systemic intravenous and local intratracheal delivery of doxorubicin (DOX), antisense oligonucleotides (ASO) and small interfering RNA (siRNA).

Methods: "Neutral" and cationic liposomes were used to deliver DOX, ASO, and siRNA. Liposomes were characterized by dynamic light scattering, zeta-potential, and atomic force microscopy. Cellular internalization of DOX, ASO and siRNA was studied by confocal microscopy on human lung carcinoma cells. In vivo experiments were carried out on nude mice with an orthotopic model of human lung cancer.

Results: Liposomes provided for an efficient intracellular delivery of DOX, ASO, and siRNA in vitro. Intratracheal delivery of both types of liposomes in vivo led to higher peak concentrations and much longer retention of liposomes, DOX, ASO and siRNA in the lungs when compared with systemic administration. It was found that local intratracheal treatment of lung cancer with liposomal DOX was more efficient when compared with free and liposomal DOX delivered intravenously.

Conclusions: The present study outlined the clear advantages of local intratracheal delivery of liposomal drugs for the treatment of lung cancer when compared with systemic administration of the same drug.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Eur J Pharm Sci. 2005 Nov;26(3-4):251-65 - PubMed
    1. J Drug Target. 2007 Aug-Sep;15(7-8):518-30 - PubMed
    1. Int J Nanomedicine. 2007;2(4):675-88 - PubMed
    1. Clin Cancer Res. 2008 Jun 1;14(11):3607-16 - PubMed
    1. Proc Natl Acad Sci U S A. 1988 Nov;85(21):8067-71 - PubMed

Publication types

MeSH terms

LinkOut - more resources